Indonesian path labs and TB diagnostics to get boost from $18m grants
This article was originally published in Clinica
Indonesia's pathology laboratories will be renovated and TB case detection and diagnosis activities intensified under agreements signed today between the government and the Global Fund to Fight AIDS, TB and Malaria, worth up to US$90m over five years.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.